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“tumoral repopulation”, “radiotherapy delays”, “treatment interruptions”, “overall treatment time”, etc. Additionally, we traced
the bibliographic references indicated in the articles previously selected. Special attentionwas paid in the quality of data reported,
carefully divided into univariate or multivariate analysis.
Results. Fifty-ﬁve papers were considered to ﬁt the purposes of the present study: 49 original data from retrospective series and 3
were pooled-data analysis of previously published series, with a median of 426 patients per article (range 42–4668). The other 3
papers included one editorial, one commentary and a literature review. Larynx was the most frequently reported site (22 articles,
40%), followed by mixed locations (19 articles, 35%) and oropharynx (5 articles, 9%). The majority of the original and pooled-data
studies (46/52–88.4%) showed some evidence of a negative relationship between OTT prolongation and LRC or SV. From 50 articles
that analyzed LRC, 44 (88%) showed a signiﬁcant deleterious effect of OTT prolongation, 27 of them by multivariate analyses.
And from 16 articles reporting SV data, 14 (87.5%) showed the same effect, 10 of them by multivariate analyses.
Conclusions. Consistent evidence exists about a negative outcome in LRC and SV, when OTT is prolonged during a RT course
for H&NC. Over 88% of the studies reporting LRC and/or SV endpoints showed its detrimental effect, mostly by multivariate
analysis of restrospective data. Taking into account the overwhelming ethical difﬁculties to perform any randomized clinical
trial, prospective or retrospective observational studies are the unique evidence available to deal with this important issue.
http://dx.doi.org/10.1016/j.rpor.2013.03.377
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Introduction. Medulloblastoma is the most common malignant childhood brain tumor. Radiotherapy to the craniospinal axis (CSI)
with a boost to the posterior fossa has been standard practice. The standard for CSI has been photon therapy that included
opposed lateral cranial ﬁelds and either single or multiple posterior spinal ﬁelds in prone position, in order to conﬁrm the
junction shifts. This is an uncomfortable and difﬁcult position for children. The new irradiation techniques could help us to
improve the positioning and the reproducibility of treatment.
Methods. Standard of care treatment plans were developed in supine position in one patient for both 3D and Rapid Arc CSI. Patient
underwent computed tomography (multi-slice CT scan) simulation in the supine position. Differences in planswere evaluated for
various dosimetric parameters for the target volumen and normal tissues. Three dosimetric parameters were evaluated for the
CTV: the maximum dose (Dmax), the conformity index (CI: VRx/VEv) and the heterogeneity index (HI: D5%/D95%). We evaluated
V20, V15, V10 and V5 for six partially in-ﬁeld and out-of-ﬁeld organs.
Results. Four arcs/two isocentres/table 0◦ were employed in Rapid Arc plan and four ﬁelds/two isocentres/table in 0◦ and 90◦ in
3D plan. CI were 0.99 and 0.90 for Rapid Arc and 3D plans respectively, indicating that the dose distribution conformed well to
the CTV and it is better for Rapid Arc. Moreover, Dmax was greater for 3D plan (higher doses to a large percentage of volumen)
and the same for HI indicating a more heterogeneous distribution. When we compared the results in relation to normal tissues,
all values related to V20, V15 and V10 were higher for 3D plan than for Rapid Arc plan.
Conclusions. CSI with Rapid Arc technique in supine position is feasible, safety and reproductible, face-lifting the treatment
(comfortable positioning, no table movements) and reducing dose to normal tissues in children population who are at high risk
of developing late toxicities.
http://dx.doi.org/10.1016/j.rpor.2013.03.378
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Introduction. Total body irradiation (TBI) has an established role as preparative regimen for bone-marrow transplantation (BMT) in
the treatment of some hematological malignancies. This preparative regimen remains always associated with a relatively high
rate of toxicity.
Objective. Report the experience in TBI treatment the last 5 years in our Hospital.
Materials and methods. We report a retrospective analysis of the patients who underwent TBI for conditioning prior to BMT for
hematologic disease between January/2006 and December/2011. Were treated 12 patients (8 women and 4 men), the age of the
patients was between 9 and 54 years (median 29.5years). They had diagnoses of LLA in 58.4% and LMA in 41.6%. Eleven patients
had induction chemotherapy with PETHEMA and one with SHOP. Complete response before radiotherapy in 66.6% and partial
in 33.3%. Radiotherapy was administrated with cobalt-60 in 25% and linear accelerator in 75%. All of them received 12Gy twice
daily along 3 days. Pulmonary dose was ≤8Gy. Transplant allogeneic in 75% and autologus in 25%.
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Results. Radiotherapy was well tolerated with complete remission in 83.4% of them. Acute toxicities were low grade nausea and
vomiting, without late toxicity. The median follow-up are 48 months, actually 7 patients are disease-free, 2 with cutaneous EICH.
The other 5 patients are dead, 3 of them by relapse.
Conclusion. TBI has been a central part of allogenic transplantation for LMA and LLA, with chemotherapy is used to destroy
disordered cells and to immunosuppress prior to transplantation for decrease the EICH. The TBI has a relative advantage in its
using is that the dose delivery throughout the body is controllable in each organ. In our review the results are similar than the
others series published with overall-survival (range 45–65%), the transplant related mortality (ranged 20–22%) and the probability
of relapse (range 20–40%).
http://dx.doi.org/10.1016/j.rpor.2013.03.379
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Introduction. Fractionated stereotactic radiotherapy (FSRT) is an advantage strategy in pediatric brain tumors treatment.
Purpose. This study attempts to analyses our experience in terms of local control overall survival and acute and late toxicities
with FSRT in pediatrics patients with brain tumors.
Methods. Between February 2008 and December 2012, nine children with brain tumors were treated with FSRT: three pilocytic
astrocytomas, two glioma stem, pineal endodermal tumor, anaplastic ganglioglioma, PNET pineal and Ewing’s sarcoma intracra-
nial recurrence. 3-T MRI was performed previously to treatment administration. Subsequently a CT with Brainlab thermoplastic
mask was carried out, using a Frameless system that provides accurate daily set up. CT image fusion MRI and an iPlan planning
systemwereperformed for dosimetry. All patients received 50–54Gywith 3Dconformal radiotherapyor IntensityModulatedRadi-
ation Therapy “sliding windows” (diffuse glioma recurrence stem and recurrence Ewing’s sarcoma) in a Novalis Linac (Brainlab®),
adapted to stereotactic treatments. Daily veriﬁcation of the treatment was performed with IGRT Exactrac® system, using a 6D
robotic couch, infrared camera andorthogonal X-rays. Toxicitywas assessed according toNCICTCvs 4.0. Local-failure free survival
and overall survival (LFFS) was obtained using the Kaplan–Meier method.
Results. Median follow up from the primary diagnosis was 54 months (5–131). Local recurrence was observed in 4 patients (the 5
year actuarial LFFS rate was 58.9%) and actuarial overall survival was 60.6% at 5 year. The treatment in all cases was well tolerated
and no grade >3 acute and late neurological toxicities due to the radiotherapy treatment were reported.
Conclusion. The FRST with IGRT is a feasible, safety and accurate treatment for pediatric brain tumors, although the small sample
size evaluated. Beneﬁts and toxicities of this approach should be assessed in prospective clinical trials in order to deﬁne the role
of FSRT in pediatric brain tumors.
http://dx.doi.org/10.1016/j.rpor.2013.03.380
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Introduction. First described by Billroth in 1856, ACC is a rare pathologic ﬁnding that comprises 10% of salivary gland neoplasms.
The most common type is squamous cell carcinoma. The management is challenging because of its insidious growth pattern
(perineural involvement) and tendency for distant metastasis. Surgery represents the main treatment. No deﬁnitive policy exists
regarding postoperative radiotherapy (RT) or elective node treatment. Research is lacking on newer radiation techniques. RT is
recommended to help local control if skull base, neck metastasis, perineural invasion or relapse. We present the case of a patient
with ACC of the external ear treated by intensity-modulated radiotherapy (IMRT).
Materials and method (case report). A 36 year-old female visited the ENT clinic with a three years history of otalgia, and hearing loss.
Physical examination, MR and PET-CT scan revealed an expansive lesion in the upper-posterior wall of the EAC. Biopsy: ACC. The
patient underwent a radical surgery, including bone samples and right neck dissection. Pathology: AAC with perineural, mastoid
and EAC wall invasion. No pathologic lymph nodes. Postoperative IMRT-IGRT was started at our institution in July 2012. MRI and
PET CT scan were reviewed for target delineation. The target volume was deﬁned as the surgical bed and suspicious areas with
a 0.3 cm margin. Technique: step and shoot IMRT (8 beams, with 38 segments). Prescribed dose: 66Gy at 2Gy per fraction
Results. The patient was seen after RT with controversial results as PET-CT showed local activity. Re-assessment with surgery
and MRI scan revealed no pathologic ﬁndings. With 6 months follow-up time, there is no evidence of disease. No severe toxicity
has been reported.
